Robert B Diasio

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Prognostic Factors

Top Venues

JCO precision oncology

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sharyn D Baker, Susan E Bates, Gabriel A Brooks, William L Dahut, Robert B Diasio, Wafik S El-Deiry, William E Evans, William Douglas Figg, Daniel Louis Hertz, J Kevin Hicks, Suneel D Kamath, Pashtoon Murtaza Kasi, Todd C Knepper, Howard L McLeod, Peter H O'Donnell, Mary V Relling, Michelle A Rudek, Tristan M Sissung, D Max Smith, Alex Sparreboom, Sandra M Swain, Christine M Walko
DPYD Testing: Time to Put Patient Safety First. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Melissa A Lumish, Jennifer Thackray, Richard Kinh Gian Do, Kelly E Caudle, Ursula Amstutz, Matthias Schwab, Robert B Diasio, William R Jarnagin, Andrea Cercek
Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine. JCO precision oncology 7 (2023)
Melissa A Lumish, Jennifer Thackray, Richard Kinh Gian Do, Kelly E Caudle, Ursula Amstutz, Matthias Schwab, Robert B Diasio, William R Jarnagin, Andrea Cercek
Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine. JCO precision oncology 7 (2023)
Melissa A Lumish, Jennifer Thackray, Richard Kinh Gian Do, Kelly E Caudle, Ursula Amstutz, Matthias Schwab, Robert B Diasio, William R Jarnagin, Andrea Cercek
Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine. JCO precision oncology 7 (2023)
Daniel A King, Robert B Diasio, Muhammad Wasif Saif
Association of Pharmacogenetics With Adverse Events of Fluorouracil/Capecitabine in Patients With Cancer. JCO oncology practice 17 (7) (2021)
Seid Hamzic, Dominic Schärer, Steven M Offer, Didier Meulendijks, Christos Theodoros Nakas, Robert B Diasio, Stefano Fontana, Marc Wehrli, Stefan Schürch, Ursula Amstutz, Carlo R Largiadèr
Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity. British journal of clinical pharmacology 87 (8) (2021)